Optimal management of chronic graft-versus-host disease in children: Review

British Journal of Haematology

Volumn 150, Issue 3, 2010, Pages 278-292

  Jacobsohn, David A ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

allogeneic haematopoietic stem cell transplantation; chronic GVHD; graft versus host disease; paediatric

Indexed keywords

CYCLOSPORIN; METHOTREXATE; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTHROPATHY; CHILD; CHILDHOOD MORTALITY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; FASCIA DISEASE; GASTROINTESTINAL DISEASE; GENITAL SYSTEM DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG DISEASE; MORBIDITY; MOUTH DISEASE; MUSCLE DISEASE; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SKIN MANIFESTATION;

CHILD; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; RISK FACTORS; SALVAGE THERAPY;

EID: 77954574611     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08247.x     Document Type: Review

References (130)

1. Akosa, A.B. Lampert, I.A. (1990) The sweat gland in graft versus host disease. The Journal of Pathology, 161, 261 266.
2. Akpek, G., Valladares, J.L., Lee, L., Margolis, J. Vogelsang, G.B. (2001a) Pancreatic insufficiency in patients with chronic graft-versus-host disease. Bone Marrow Transplantation, 27, 163 166. (Pubitemid 32156870)
3. Akpek, G., Zahurak, M.L., Piantadosi, S., Margolis, J., Doherty, J., Davidson, R. Vogelsang, G.B. (2001b) Development of a prognostic model for grading chronic graft-versus-host disease. Blood, 97, 1219 1226. (Pubitemid 32183742)
4. Akpek, G., Lee, S.M., Anders, V. Vogelsang, G.B. (2001c) A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 7, 495 502.
5. Akpek, G., Boitnott, J.K., Lee, L.A., Hallick, J.P., Torbenson, M., Jacobsohn, D.A., Arai, S., Anders, V. Vogelsang, G.B. (2002) Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood, 100, 3903 3907.
6. Akpek, G., Lee, S.J., Flowers, M.E., Pavletic, S.Z., Arora, M., Lee, S., Piantadosi, S., Guthrie, K.A., Lynch, J.C., Takatu, A., Horowitz, M.M., Antin, J.H., Weisdorf, D.J., Martin, P.J. Vogelsang, G.B. (2003) Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood, 102, 802 809.
7. Albert, M.H., Becker, B., Schuster, F.R., Klein, B., Binder, V., Adam, K., Nienhoff, C., Fuhrer, M. Borkhardt, A. (2007) Oral graft vs. host disease in children - treatment with topical tacrolimus ointment. Pediatric Transplantation, 11, 306 311.
8. Andrews, M.L., Robertson, I. Weedon, D. (1997) Cutaneous manifestations of chronic graft-versus-host disease. The Australasian Journal of Dermatology, 38, 53 62.
9. Arai, S., Lee, L. Vogelsang, G. (2002) A systematic approach to hepatic complications in hematopoietic stem cell transplantation. Journal of Hematotherapy and Stem Cell Research, 11, 215 230.
10. Arora, M., Nagaraj, S., Witte, J., Defor, T.E., Macmillan, M., Burns, L.J. Weisdorf, D.J. (2009) New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplantation, 43, 149 153.
11. Atkinson, K. (1990) Chronic graft-versus-host disease. Bone Marrow Transplantation, 5, 69 82.
12. Au, W.Y., Lo, C.M., Hawkins, B.R., Ma, E.S., Lie, A.K. Kwong, Y.L. (2001) Evans' syndrome complicating chronic graft versus host disease after cadaveric liver transplantation. Transplantation, 72, 527 528.
13. Bacigalupo, A., Lamparelli, T., Barisione, G., Bruzzi, P., Guidi, S., Alessandrino, P.E., di Bartolomeo, P., Oneto, R., Bruno, B., Sacchi, N., van Lint, M.T. Bosi, A. (2006) Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biology of Blood and Marrow Transplantation, 12, 560 565.
14. Beredjiklian, P.K., Drummond, D.S., Dormans, J.P., Davidson, R.S., Brock, G.T. August, C. (1998) Orthopaedic manifestations of chronic graft-versus-host disease. Journal of Pediatric Orthopaedics, 18, 572 575.
15. Berger, M., Pessolano, R., Albiani, R., Asaftei, S., Barat, V., Carraro, F., Biasin, E., Madon, E. Fagioli, F. (2007) Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. Journal of Pediatric Hematology/Oncology, 29, 678 687.
16. Bergeron, A., Belle, A., Chevret, S., Ribaud, P., Devergie, A., Esperou, H., Ades, L., Gluckman, E., Socie, G. Tazi, A. (2007) Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplantation, 39, 547 553.
17. Berkowitz, R.J., Strandjord, S., Jones, P., Hughes, C., Barsetti, J., Gordon, E.M., Cheung, N.K., Warkentin, P. Coccia, P.F. (1987) Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatric Dentistry, 9, 105 110.
18. Boeckh, M., Leisenring, W., Riddell, S.R., Bowden, R.A., Huang, M.L., Myerson, D., Stevens-Ayers, T., Flowers, M.E., Cunningham, T. Corey, L. (2003) Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood, 101, 407 414.
19. Bolanos-Meade, J. Vogelsang, G.B. (2008) Chronic graft-versus-host disease. Current Pharmaceutical Design, 14, 1974 1986.
20. Bolaños-Meade, J., Jacobsohn, D.A., Margolis, J., Ogden, A., Wientjes, M.G., Byrd, J.C., Lucas, D.M., Anders, V., Phelps, M., Grever, M.R. Vogelsang, G.B. (2005) Pentostatin in steroid-refractory acute graft-versus-host disease. Journal of Clinical Oncology, 23, 2661 2668. (Pubitemid 46179455)
21. Browning, B., Thormann, K., Seshadri, R., Duerst, R., Kletzel, M. Jacobsohn, D.A. (2006) Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease. Bone Marrow Transplantation, 37, 527 533.
22. Bunin, N., Carston, M., Wall, D., Adams, R., Casper, J., Kamani, N. King, R. (2002) Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood, 99, 3151 3157.
23. Bunin, N.J., Davies, S.M., Aplenc, R., Camitta, B.M., DeSantes, K.B., Goyal, R.K., Kapoor, N., Kernan, N.A., Rosenthal, J., Smith, F.O. Eapen, M. (2008) Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. Journal of Clinical Oncology, 26, 4326 4332.
24. Busca, A., Saroglia, E.M., Lanino, E., Manfredini, L., Uderzo, C., Nicolini, B., Messina, C., Rabusin, M. Miniero, R. (2000) Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplantation, 25, 1067 1071.
25. Canaday, D.H., Chakravarti, S., Srivastava, T., Tisch, D.J., Cheruvu, V.K., Smialek, J., Harding, C.V. Ramachandra, L. (2006) Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression. Cellular Immunology, 243, 96 106.
26. Carpenter, P.A., Hoffmeister, P., Chesnut, III., C.H., Storer, B., Charuhas, P.M., Woolfrey, A.E. Sanders, J.E. (2007) Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 13, 683 690.
27. Champlin, R.E., Schmitz, N., Horowitz, M.M., Chapuis, B., Chopra, R., Cornelissen, J.J., Gale, R.P., Goldman, J.M., Loberiza, Jr., F.R., Hertenstein, B., Klein, J.P., Montserrat, E., Zhang, M.J., Ringden, O., Tomany, S.C., Rowlings, P.A., Van Hoef, M.E. Gratwohl, A. (2000) Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR histocompatibility and stem cell sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood, 95, 3702 3709.
28. Chien, J.W., Duncan, S., Williams, K.M. Pavletic, S.Z. (2010) Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 16, S106 S114.
29. Cho, B.S., Min, C.K., Eom, K.S., Kim, Y.J., Kim, H.J., Lee, S., Cho, S.G., Kim, D.W., Lee, J.W., Min, W.S. Kim, C.C. (2009) Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia, 23, 78 84.
30. Choi, C.J. Nghiem, P. (2001) Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Archives of Dermatology, 137, 1202 1206.
31. Clark, J.G., Schwartz, D.A., Flournoy, N., Sullivan, K.M., Crawford, S.W. Thomas, E.D. (1987) Risk factors for airflow obstruction in recipients of bone marrow transplants. Annals of Internal Medicine, 107, 648 656.
32. Clark, J.G., Crawford, S.W., Madtes, D.K. Sullivan, K.M. (1989) Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Annals of Internal Medicine, 111, 368 376.
33. Couriel, D., Carpenter, P.A., Cutler, C., Bolanos-Meade, J., Treister, N.S., Gea-Banacloche, J., Shaughnessy, P., Hymes, S., Kim, S., Wayne, A.S., Chien, J.W., Neumann, J., Mitchell, S., Syrjala, K., Moravec, C.K., Abramovitz, L., Liebermann, J., Berger, A., Gerber, L., Schubert, M., Filipovich, A.H., Weisdorf, D., Schubert, M.M., Shulman, H., Schultz, K., Mittelman, B., Pavletic, S., Vogelsang, G.B., Martin, P.J., Lee, S.J. Flowers, M.E. (2006) Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation, 12, 375 396. (Pubitemid 43380955)
34. Crawford, S.W. Clark, J.G. (1993) Bronchiolitis associated with bone marrow transplantation. Clinics in Chest Medicine, 14, 741 749.
35. Creamer, D., Martyn-Simmons, C.L., Osborne, G., Kenyon, M., Salisbury, J.R., Devereux, S., Pagliuca, A., Ho, A.Y., Mufti, G.J. du Vivier, A.W. (2007) Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Archives of Dermatology, 143, 1157 1162.
36. Cuthbert, R.J., Iqbal, A., Gates, A., Toghill, P.J. Russell, N.H. (1995) Functional hyposplenism following allogeneic bone marrow transplantation. Journal of Clinical Pathology, 48, 257 259.
37. Cutler, C., Giri, S., Jeyapalan, S., Paniagua, D., Viswanathan, A. Antin, J.H. (2001) Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. Journal of Clinical Oncology, 19, 3685 3691.
38. Cutler, C., Miklos, D., Kim, H.T., Treister, N., Woo, S.B., Bienfang, D., Klickstein, L.B., Levin, J., Miller, K., Reynolds, C., Macdonell, R., Pasek, M., Lee, S.J., Ho, V., Soiffer, R., Antin, J.H., Ritz, J. Alyea, E. (2006) Rituximab for steroid-refractory chronic graft-versus-host disease. Blood, 108, 756 762. (Pubitemid 44061381)
39. Dahllof, G., Heimdahl, A., Bolme, P., Lonnqvist, B. Ringden, O. (1988) Oral condition in children treated with bone marrow transplantation. Bone Marrow Transplantation, 3, 43 51. (Pubitemid 18055521)
40. Dudek, A.Z., Mahaseth, H., Defor, T.E. Weisdorf, D.J. (2003) Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biology of Blood and Marrow Transplantation, 9, 657 666.
41. Duncan, C.N., Buonanno, M.R., Barry, E.V., Myers, K., Peritz, D. Lehmann, L. (2008) Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 41, 971 975.
42. Eapen, M., Horowitz, M.M., Klein, J.P., Champlin, R.E., Loberiza, Jr., F.R., Ringden, O. Wagner, J.E. (2004) Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Journal of Clinical Oncology, 22, 4872 4880.
43. Eapen, M., Rubinstein, P., Zhang, M.J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F.R., Champlin, R.E., Klein, J.P., Horowitz, M.M. Wagner, J.E. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet, 369, 1947 1954.
44. van Ede, A.E., Laan, R.F., Blom, H.J., De Abreu, R.A. van de Putte, L.B. (1998) Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Seminars in Arthritis and Rheumatism, 27, 277 292.
45. Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K. Plewig, G. (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. The New England Journal of Medicine, 316, 297 303.
46. Elad, S., Or, R., Resnick, I. Shapira, M.Y. (2003) Topical tacrolimus - a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transplant International, 16, 665 670.
47. Filipovich, A.H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J.R., Lee, S.J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., Cowen, E.W., Dinndorf, P., Farrell, A., Hartzman, R., Henslee-Downey, J., Jacobsohn, D., McDonald, G., Mittleman, B., Rizzo, J.D., Robinson, M., Schubert, M., Schultz, K., Shulman, H., Turner, M., Vogelsang, G. Flowers, M.E. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation, 11, 945 956. (Pubitemid 41754712)
48. Flowers, M.E., Parker, P.M., Johnston, L.J., Matos, A.V., Storer, B., Bensinger, W.I., Storb, R., Appelbaum, F.R., Forman, S.J., Blume, K.G. Martin, P.J. (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood, 100, 415 419.
49. Flowers, M.E., Apperley, J.F., van Besien, K., Elmaagacli, A., Grigg, A., Reddy, V., Bacigalupo, A., Kolb, H.J., Bouzas, L., Michallet, M., Prince, H.M., Knobler, R., Parenti, D., Gallo, J. Greinix, H.T. (2008) A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood, 112, 2667 2674.
50. Fraser, C.J. Scott, B.K. (2007) The management and outcome of chronic graft-versus-host disease. British Journal of Haematology, 138, 131 145.
51. Garderet, L., Dulphy, N., Douay, C., Chalumeau, N., Schaeffer, V., Zilber, M.T., Lim, A., Even, J., Mooney, N., Gelin, C., Gluckman, E., Charron, D. Toubert, A. (1998) The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood, 91, 340 346.
52. Gilman, A.L. Serody, J. (2006) Diagnosis and treatment of chronic graft-versus-host disease. Seminars in Hematology, 43, 70 80.
53. Gilman, A.L., Chan, K.W., Mogul, A., Morris, C., Goldman, F.D., Boyer, M., Cirenza, E., Mazumder, A., Gehan, E., Cahill, R., Frankel, S. Schultz, K. (2000) Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 6, 327 334.
54. Goldberg, J.D., Jacobsohn, D.A., Margolis, J., Chen, A.R., Anders, V., Phelps, M. Vogelsang, G.B. (2003) Pentostatin for the treatment of chronic graft-versus-host disease in children. Journal of Pediatric Hematology/Oncology, 25, 584 588.
55. Green, A., Clarke, E., Hunt, L., Canterbury, A., Lankester, A., Hale, G., Waldmann, H., Goodman, S., Cornish, J.M., Marks, D.I., Steward, C.G., Oakhill, A. Pamphilon, D.H. (1999) Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood, 94, 2236 2246.
56. Greinix, H.T., Pohlreich, D., Maalouf, J., Soukup, P., Supper, V., Kalhs, P. Knobler, R.M. (2007) A single-center pilot validation study of a new chronic GVHD skin scoring system. Biology of Blood and Marrow Transplantation, 13, 715 723.
57. Heald, P., Perez, M., McKiernan, G., Christiensen, I. Edelson, R. (1989) Extracorporeal photochemotherapy: indications, methodology, safety aspects, side effects and long-term results. Photo-dermatology, 6, 171 176.
58. Higman, M., Vogelsang, G.B. Chen, A. (2004) Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease. Expert Opinion on Pharmacotherapy, 5, 2605 2613.
59. Holland, H.K., Wingard, J.R., Beschorner, W.E., Saral, R. Santos, G.W. (1988) Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood, 72, 621 627.
60. Hovi, L., Kurimo, M., Taskinen, M., Vettenranta, J., Vettenranta, K. Saarinen-Pihkala, U.M. (2010) Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT. Bone Marrow Transplantation, 45, 738 745.
61. Inagaki, J., Nagatoshi, Y., Hatano, M., Isomura, N., Sakiyama, M. Okamura, J. (2008) Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children. Bone Marrow Transplantation, 41, 571 577.
62. Iqbal, N., Salzman, D., Lazenby, A.J. Wilcox, C.M. (2000) Diagnosis of gastrointestinal graft-versus-host disease. The American Journal of Gastroenterology, 95, 3034 3038.
63. Jacobsohn, D.A., Montross, S., Anders, V. Vogelsang, G.B. (2001) Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease. Bone Marrow Transplantation, 28, 1047 1051.
64. Jacobsohn, D.A., Ruble, K., Moresi, J.M. Vogelsang, G.B. (2002) Rapid-onset leucodrema associated with graft-versus-host disease. Bone Marrow Transplantation, 30, 705 706.
65. Jacobsohn, D.A., Schechter, T., Seshadri, R., Thormann, K., Duerst, R. Kletzel, M. (2004) Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children. Transplantation, 77, 1096 1100.
66. Jacobsohn, D.A., Chen, A.R., Zahurak, M., Piantadosi, S., Anders, V., Bolanos-Meade, J., Higman, M., Margolis, J., Kaup, M. Vogelsang, G.B. (2007) Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. Journal of Clinical Oncology, 25, 4255 4261.
67. Jacobsohn, D.A., Gilman, A.L., Rademaker, A., Browning, B., Grimley, M., Lehmann, L., Nemecek, E.R., Thormann, K., Schultz, K.R. Vogelsang, G.B. (2009) Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study. Blood, 114, 4354 4360.
68. Jagasia, M.H., Savani, B.N., Stricklin, G., Engelhardt, B., Kassim, A., Dixon, S., Chen, H., Chinratanalab, W., Goodman, S., Greer, J.P. Schuening, F. (2009) Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biology of Blood and Marrow Transplantation, 15, 1288 1295.
69. Janin, A., Socie, G., Devergie, A., Aractingi, S., Esperou, H., Verola, O. Gluckman, E. (1994) Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Annals of Internal Medicine, 120, 993 998.
70. Johnson, D.A. Jabs, D.A. (1997) The ocular manifestations of graft-versus-host disease. International Ophthalmology Clinics, 37, 119 133.
71. Johnston, L.J., Brown, J., Shizuru, J.A., Stockerl-Goldstein, K.E., Stuart, M.J., Blume, K.G., Negrin, R.S. Chao, N.J. (2005) Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 11, 47 55.
72. Kawano, N., Gondo, H., Kamimura, T., Aoki, K., Iino, T., Ishikawa, F., Miyamoto, T., Nagafuji, K., Shimoda, K., Hayashi, S., Otsuka, T., Kazuyama, Y. Harada, M. (2003) Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. International Journal of Hematology, 78, 370 373.
73. Khouri, I.F., Ippoliti, C., Gajewski, J., Przepiorka, D. Champlin, R.E. (1996) Neutropenias following allogeneic bone marrow transplantation: response to therapy with high-dose intravenous immunoglobulin. American Journal of Hematology, 52, 313 315.
74. Kilgour, G., McNair, P. Stott, N.S. (2003) Intrarater reliability of lower limb sagittal range-of-motion measures in children with spastic diplegia. Developmental Medicine and Child Neurology, 45, 391 399.
75. Kilgour, G.M., McNair, P.J. Stott, N.S. (2005) Range of motion in children with spastic diplegia, GMFCS I-II compared to age and gender matched controls. Physical and Occupational Therapy in Pediatrics, 25, 61 79.
76. Koc, S., Leisenring, W., Flowers, M.E., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Storb, R., Appelbaum, F.R. Martin, P.J. (2002) Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood, 100, 48 51.
77. Kulkarni, S., Powles, R., Treleaven, J., Riley, U., Singhal, S., Horton, C., Sirohi, B., Bhagwati, N., Meller, S., Saso, R. Mehta, J. (2000) Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood, 95, 3683 3686.
78. Lee, S.J., Klein, J.P., Barrett, A.J., Ringden, O., Antin, J.H., Cahn, J.Y., Carabasi, M.H., Gale, R.P., Giralt, S., Hale, G.A., Ilhan, O., McCarthy, P.L., Socie, G., Verdonck, L.F., Weisdorf, D.J. Horowitz, M.M. (2002) Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood, 100, 406 414.
79. Lee, S.J., Vogelsang, G. Flowers, M.E. (2003) Chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 9, 215 233.
80. Lelli, Jr., G.J., Musch, D.C., Gupta, A., Farjo, Q.A., Nairus, T.M. Mian, S.I. (2006) Ophthalmic cyclosporine use in ocular GVHD. Cornea, 25, 635 638.
81. Locatelli, F., Giorgiani, G., Pession, A. Bozzola, M. (1993) Late effects in children after bone marrow transplantation: a review. Haematologica, 78, 319 328.
82. Lopez, F., Parker, P., Nademanee, A., Rodriguez, R., Al Kadhimi, Z., Bhatia, R., Cohen, S., Falk, P., Fung, H., Kirschbaum, M., Krishnan, A., Kogut, N., Molina, A., Nakamura, R., O'Donnell, M., Popplewell, L., Pullarkat, V., Rosenthal, J., Sahebi, F., Smith, E., Snyder, D., Somlo, G., Spielberger, R., Stein, A., Sweetman, R., Zain, J. Forman, S. (2005) Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 11, 307 313.
83. Maes, B.D., Dalle, I., Geboes, K., Oellerich, M., Armstrong, V.W., Evenepoel, P., Geypens, B., Kuypers, D., Shipkova, M., Geboes, K. Vanrenterghem, Y.F. (2003) Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation, 75, 665 672.
84. Martin, P.J., Storer, B.E., Rowley, S.D., Flowers, M.E., Lee, S.J., Carpenter, P.A., Wingard, J.R., Shaughnessy, P.J., Devetten, M.P., Jagasia, M., Fay, J.W., van Besien, K., Gupta, V., Kitko, C., Johnston, L.J., Maziarz, R.T., Arora, M., Jacobson, P.A. Weisdorf, D. (2009) Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood, 113, 5074 5082.
85. McDonald, G.B., Shulman, H.M., Sullivan, K.M. Spencer, G.D. (1986) Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology, 90, 460 477.
86. Meisel, R., Laws, H.J., Balzer, S., Bernbeck, B., Kramm, C., Schonberger, S., Sinha, K., Troger, A., Schmitz, M., Fischer, J., Gobel, U., Enczmann, J. Dilloo, D. (2007) Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biology of Blood and Marrow Transplantation, 13, 1338 1345.
87. Melin-Aldana, H., Thormann, K., Duerst, R., Kletzel, M. Jacobsohn, D.A. (2007) Hepatitic pattern of graft versus host disease in children. Pediatric Blood and Cancer, 49, 727 730.
88. Messina, C., Locatelli, F., Lanino, E., Uderzo, C., Zacchello, G., Cesaro, S., Pillon, M., Perotti, C., Del Fante, C., Faraci, M., Rivabella, L., Calore, E., De Stefano, P., Zecca, M., Giorgiani, G., Brugiolo, A., Balduzzi, A., Dini, G., Zanesco, L. Dall'Amico, R. (2003) Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. British Journal of Haematology, 122, 118 127.
89. Mookerjee, B., Altomonte, V. Vogelsang, G. (1999) Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplantation, 24, 517 520.
90. Nagler, A., Goldenhersh, M.A., Levi-Schaffer, F., Bystryn, J.C. Klaus, S.N. (1996a) Total leucoderma: a rare manifestation of cutaneous chronic graft- versus-host disease. The British Journal of Dermatology, 134, 780 783.
91. Nagler, R., Marmary, Y., Krausz, Y., Chisin, R., Markitziu, A. Nagler, A. (1996b) Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplantation, 17, 219 224.
92. Papadimitriou, J.C., Cangro, C.B., Lustberg, A., Khaled, A., Nogueira, J., Wiland, A., Ramos, E., Klassen, D.K. Drachenberg, C.B. (2003) Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. International Journal of Surgical Pathology, 11, 295 302.
93. Parikh, S.H., Mendizabal, A., Martin, P.L., Prasad, V.K., Szabolcs, P., Driscoll, T.A. Kurtzberg, J. (2009) Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience. Biology of Blood and Marrow Transplantation, 15, 948 955.
94. Pavletic, S.Z., Carter, S.L., Kernan, N.A., Henslee-Downey, J., Mendizabal, A.M., Papadopoulos, E., Gingrich, R., Casper, J., Yanovich, S. Weisdorf, D. (2005) Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood, 106, 3308 3313.
95. Pavletic, S.Z., Martin, P., Lee, S.J., Mitchell, S., Jacobsohn, D., Cowen, E.W., Turner, M.L., Akpek, G., Gilman, A., McDonald, G., Schubert, M., Berger, A., Bross, P., Chien, J.W., Couriel, D., Dunn, J.P., Fall-Dickson, J., Farrell, A., Flowers, M.E., Greinix, H., Hirschfeld, S., Gerber, L., Kim, S., Knobler, R., Lachenbruch, P.A., Miller, F.W., Mittleman, B., Papadopoulos, E., Parsons, S.K., Przepiorka, D., Robinson, M., Ward, M., Reeve, B., Rider, L.G., Shulman, H., Schultz, K.R., Weisdorf, D. Vogelsang, G.B. (2006) Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biology of Blood and Marrow Transplantation, 12, 252 266.
96. Penas, P.F., Fernandez-Herrera, J. Garcia-Diez, A. (2004) Dermatologic treatment of cutaneous graft versus host disease. American Journal of Clinical Dermatology, 5, 403 416.
97. Peritt, D. (2006) Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 7 12.
98. Rappeport, J.M., O'Reilly, R.J., Kapoor, N. Parkman, R. (2010) Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us. Immunology and Allergy Clinics of North America, 30, 17 30.
99. Ratanatharathorn, V., Ayash, L., Lazarus, H.M., Fu, J. Uberti, J.P. (2001) Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplantation, 28, 121 129.
100. Roca, J., Granena, A., Rodriguez-Roisin, R., Alvarez, P., Agusti-Vidal, A. Rozman, C. (1982) Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax, 37, 77 78.
101. Rocha, V., Wagner, Jr., J.E., Sobocinski, K.A., Klein, J.P., Zhang, M.J., Horowitz, M.M. Gluckman, E. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. The New England Journal of Medicine, 342, 1846 1854.
102. Sabry, W., Le Blanc, R., Labbe, A.C., Sauvageau, G., Couban, S., Kiss, T., Busque, L., Cohen, S., Lachance, S., Roy, D.C. Roy, J. (2009) Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality. Biology of Blood and Marrow Transplantation, 15, 919 929.
103. Salvaneschi, L., Perotti, C., Zecca, M., Bernuzzi, S., Viarengo, G., Giorgiani, G., Del Fante, C., Bergamaschi, P., Maccario, R., Pession, A. Locatelli, F. (2001) Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion, 41, 1299 1305.
104. Saven, A. Piro, L. (1994) Newer purine analogues for the treatment of hairy-cell leukemia. The New England Journal of Medicine, 330, 691 697.
105. Schimmer, A.D., Minden, M.D. Keating, A. (2000) Osteoporosis after blood and marrow transplantation: clinical aspects. Biology of Blood and Marrow Transplantation, 6, 175 181.
106. Schubert, M.M. Sullivan, K.M. (1990) Recognition, incidence, and management of oral graft-versus-host disease. NCI Monographs, 9, 135 143.
107. Schubert, M.M., Sullivan, K.M., Morton, T.H., Izutsu, K.T., Peterson, D.E., Flournoy, N., Truelove, E.L., Sale, G.E., Buckner, C.D., Storb, R. Thomas, E.D. (1984) Oral manifestations of chronic graft-v-host disease. Archives of Internal Medicine, 144, 1591 1595.
108. Shimada, K., Yokozawa, T., Atsuta, Y., Kohno, A., Maruyama, F., Yano, K., Taji, H., Kitaori, K., Goto, S., Iida, H., Morishima, Y., Kodera, Y., Naoe, T. Morishita, Y. (2005) Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplantation, 36, 115 121.
109. Shulman, H.M. Sullivan, K.M. (1988) Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. Concepts in Immunopathology, 6, 141 165.
110. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. The American Journal of Medicine, 69, 204 217.
111. Shulman, H.M., Sharma, P., Amos, D., Fenster, L.F. McDonald, G.B. (1988) A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology, 8, 463 470.
112. Souza, J.P., Boeckh, M., Gooley, T.A., Flowers, M.E. Crawford, S.W. (1999) High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clinical Infectious Diseases, 29, 1467 1471.
113. Stevens, A.M., Sullivan, K.M. Nelson, J.L. (2003) Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford), 42, 34 39.
114. Stewart, B.L., Storer, B., Storek, J., Deeg, H.J., Storb, R., Hansen, J.A., Appelbaum, F.R., Carpenter, P.A., Sanders, J.E., Kiem, H.P., Nash, R.A., Petersdorf, E.W., Moravec, C., Morton, A.J., Anasetti, C., Flowers, M.E. Martin, P.J. (2004) Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood, 104, 3501 3506.
115. Strasser, S.I., Shulman, H.M., Flowers, M.E., Reddy, R., Margolis, D.A., Prumbaum, M., Seropian, S.E. McDonald, G.B. (2000) Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology, 32, 1265 1271.
116. Sullivan, K.M., Shulman, H.M., Storb, R., Weiden, P.L., Witherspoon, R.P., McDonald, G.B., Schubert, M.M., Atkinson, K. Thomas, E.D. (1981) Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood, 57, 267 276.
117. Sullivan, K.M., Witherspoon, R.P., Storb, R., Weiden, P., Flournoy, N., Dahlberg, S., Deeg, H.J., Sanders, J.E., Doney, K.C. Appelbaum, F.R. (1988a) Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood, 72, 546 554.
118. Sullivan, K.M., Witherspoon, R.P., Storb, R., Deeg, H.J., Dahlberg, S., Sanders, J.E., Appelbaum, F.R., Doney, K.C., Weiden, P. Anasetti, C. (1988b) Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood, 72, 555 561.
119. Takahide, K., Parker, P.M., Wu, M., Hwang, W.Y., Carpenter, P.A., Moravec, C., Stehr, B., Martin, P.J., Rosenthal, P., Forman, S.J. Flowers, M.E. (2007) Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 13, 1016 1021.
120. The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group (1991) Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group. The New England Journal of Medicine, 325, 73 80.
121. Tomonari, A., Tojo, A., Lseki, T., Ooi, J., Nagayama, H., Ogami, K., Maekawa, T., Shirafuji, N., Tani, K. Asano, S. (2001) Severe autoimmune thrombocytopenia after allogeneic bone marrow transplantation for aplastic anemia. International Journal of Hematology, 74, 228 232.
122. Treister, N.S., Woo, S.B., O'Holleran, E.W., Lehmann, L.E., Parsons, S.K. Guinan, E.C. (2005) Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 11, 721 731.
123. Vogelsang, G.B. (2001) How I treat chronic graft-versus-host disease. Blood, 97, 1196 1201.
124. Vogelsang, G.B., Farmer, E.R., Hess, A.D., Altamonte, V., Beschorner, W.E., Jabs, D.A., Corio, R.L., Levin, L.S., Colvin, O.M., Wingard, J.R. Santos, G.W. (1992) Thalidomide for the treatment of chronic graft-versus-host disease. The New England Journal of Medicine, 326, 1055 1058.
125. Vowels, M., Chan, L.L., Giri, N., Russell, S. Lam-Po-Tang, R. (1993) Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplantation, 12, 347 350.
126. Wall, D.A., Carter, S.L., Kernan, N.A., Kapoor, N., Kamani, N.R., Brochstein, J.A., Frangoul, H., Goyal, R.K., Horan, J.T., Pietryga, D., Wagner, J.E. Kurtzberg, J. (2005) Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biology of Blood and Marrow Transplantation, 11, 637 646.
127. Walters, M.C., Storb, R., Patience, M., Leisenring, W., Taylor, T., Sanders, J.E., Buchanan, G.E., Rogers, Z.R., Dinndorf, P., Davies, S.C., Roberts, I.A., Dickerhoff, R., Yeager, A.M., Hsu, L., Kurtzberg, J., Ohene-Frempong, K., Bunin, N., Bernaudin, F., Wong, W.Y., Scott, J.P., Margolis, D., Vichinsky, E., Wall, D.A., Wayne, A.S., Pegelow, C., Redding-Lallinger, R., Wiley, J., Klemperer, M., Mentzer, W.C., Smith, F.O. Sullivan, K.M. (2000) Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood, 95, 1918 1924.
128. Woolfrey, A.E., Anasetti, C., Storer, B., Doney, K., Milner, L.A., Sievers, E.L., Carpenter, P., Martin, P., Petersdorf, E., Appelbaum, F.R., Hansen, J.A. Sanders, J.E. (2002) Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood, 99, 2002 2008.
129. Zauner, C., Rabitsch, W., Schneeweiss, B., Schiefermeier, M., Greinix, H.T., Keil, F., Ratheiser, K. Kalhs, P. (2001) Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease. Transplantation, 71, 524 528.
130. Zecca, M., Prete, A., Rondelli, R., Lanino, E., Balduzzi, A., Messina, C., Fagioli, F., Porta, F., Favre, C., Pession, A. Locatelli, F. (2002) Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood, 100, 1192 1200.